Buy
Sell
Share Name Share Symbol Market Type Share ISIN Share Description
Ergomed Plc LSE:ERGO London Ordinary Share GB00BN7ZCY67 ORD 1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  +0.00p +0.00% 286.00p 282.00p 290.00p 286.00p 286.00p 286.00p 53,225 08:00:00
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Pharmaceuticals & Biotechnology 54.1 -10.8 -20.0 - 133.11

Ergomed Share Discussion Threads

Showing 301 to 322 of 325 messages
Chat Pages: 13  12  11  10  9  8  7  6  5  4  3  2  Older
DateSubjectAuthorDiscuss
13/6/2019
10:15
yep - over £250k in total
bermudashorts
13/6/2019
09:41
wow - new CFO bought another 64,000 shares at 270 pence. That's £172,800.00. He must be confident.
mfhmfh
10/6/2019
09:53
good to see newly appointed CFO purchasing 36,000 shares at 241.5 pence. That's nearly £87,000 spent at near all time highs.
mfhmfh
04/6/2019
09:37
Yes, seems like a good fit.
bermudashorts
04/6/2019
09:15
good appointment of CFO today IMHO.
mfhmfh
16/5/2019
09:51
Harwood Capital LLP continue to increase their stake. hopefully a positive.
mfhmfh
16/5/2019
09:50
great announcement today IMHO: 'As a result, Ergomed now expects revenue and EBITDA for the year ending 31 December 2019 to be materially above current market expectations.'
mfhmfh
16/5/2019
09:07
Doing well now
mirabeau
16/5/2019
08:45
Very good trading announcement. Very inspired recent buying too! Pound to a penny that we’ll be having a fund raising shortly to buy more pharmacovigilance companies and maybe fund the Haemostatix Phase 3 trial. If the CVM Multikine trial is a success that would be huge.
ih_433513
09/5/2019
15:13
Thanks mfhmfm
bermudashorts
09/5/2019
14:41
Harwood Capital LLP have increased their holding.
mfhmfh
25/4/2019
14:25
nice buys coming in today
mfhmfh
23/4/2019
07:31
Nice RNS Ergomed's PrimeVigilance awarded 2019 Queen's Award for Enterprise https://investegate.co.uk/ergomed-plc--ergo-/rns/ergomed-s-primevigilance-receives-queen-s-award/201904230700087133W/
bermudashorts
10/4/2019
01:38
Wonder if they will have to write off Haemostatix? No Phase 3 deal a year after supposedly great Phase 2 results - doesn’t sound good to me. Why don’t they do it themselves? Maybe they will if Multikine turns out to be a winner. It looks like Multikine is the last chance on the partnered drugs. The only other one was the Ferrer drug and like Haemostatix the Phase 2 results were touted as great but clearly they weren’t as no partners have been found to take the drug forward into Phase 3. CROs may be good at conducting trials but they seem to be poor at knowing whether the drugs will be winners.
jamtomorrow2
09/4/2019
15:33
Buys coming in. Let's see what tomorrow brings...
mfhmfh
06/4/2019
23:08
Interesting that Cel-Sci’s share price has doubled recently on optimism that Multikine’s trial will be successful. Ergomed has an interest in this drug.
jamtomorrow2
31/1/2019
14:41
Slater Investments Ltd above 10%
mfhmfh
21/1/2019
08:29
Oryx International Growth Fund above 8%
mfhmfh
22/11/2018
14:17
big volume today
mfhmfh
06/11/2018
15:37
Octopus bailing?
jamtomorrow2
31/10/2018
16:42
Agreed - thanks for the link
sicilian_kan
31/10/2018
16:02
They have certainly pushed up thier eps for this and next year. Looks rather interesting,
sidam
Chat Pages: 13  12  11  10  9  8  7  6  5  4  3  2  Older
Your Recent History
LSE
ERGO
Ergomed
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20190618 20:39:07